Immunotherapy for Patients with Advanced Urothelial Cancer: Current Evidence and Future Perspectives. – UroToday
|
Immunotherapy for Patients with Advanced Urothelial Cancer: Current Evidence and Future Perspectives.
UroToday The responsiveness of bladder cancer to immunotherapy was first established in nonmuscle invasive disease in 1976 with intravesical instillations of bacillus Calmette-Guérin (BCG). Very recently immune checkpoint inhibitors demonstrated good activity … |
